The I-KAN Study: Internet Initiation of Insulin for Type 2 Diabetes in Kansas
The I-KAN Study demonstrates the feasibility and safety of an innovative Internet-based education model for insulin management in Type 2 Diabetes patients, particularly in rural areas. Given the increasing prevalence of diabetes and the need for effective management solutions, this model could represent a significant opportunity for healthcare providers and digital health companies. The findings may support further development of telehealth solutions and educational platforms, potentially leading to partnerships with pharmaceutical companies that manufacture insulin products. The study's outcomes could also influence reimbursement policies for digital health interventions, enhancing market access for similar future initiatives.
Indication: Type 2 Diabetes
Modality: behavioral intervention
Target: Basal insulin administration for Type 2 Diabetes management
Sponsor: David Robbins, MD
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 17, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Basal insulin administration for Type 2 Diabetes management
View original source fields
Condition raw: Type 2 Diabetes
Condition normalized: Type 2 Diabetes
Modality raw: behavioral intervention
Modality normalized: behavioral intervention
Target raw: Basal insulin administration for Type 2 Diabetes management
Target normalized: Basal insulin administration for Type 2 Diabetes management